Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Peginterferon alpha 2b biosimilar - Zydus Cadila

Next Previous
Drug Profile

Peginterferon alpha 2b biosimilar - Zydus Cadila

Alternative Names: Peg IFN α-2b; PegiHep; Pegylated interferon alpha-2b; Virafin

Latest Information Update: 18 Jul 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Zydus Cadila
  • Class Antihaemorrhagics; Antineoplastics; Antiretrovirals; Antivirals; Immunotherapies; Interferons; Polyethylene glycols; Skin disorder therapies
  • Mechanism of Action Interferon alpha-2 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Condylomata acuminata; COVID 2019 infections; Hepatitis B; Hepatitis C

Most Recent Events

  • 21 Jun 2022 Cadila Healthcare terminates a phase II clinical trial in COVID-2019 infections in Mexico (Parenteral) due to non availability of eligible patients and slow recruitment(NCT04480138)
  • 23 Apr 2021 Launched for COVID-2019 infections in India (SC)
  • 23 Apr 2021 Registered for COVID-2019 infections (Restricted Emergency Use Approval in adults) in India (SC)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top